Dicerna Pharmaceuticals (DRNA) is Trading Lower on Unusual Volume for December 21

Equities Staff |

Dicerna Pharmaceuticals (DRNA) experienced unusually high volume on Dec. 21, as the stock lost 0.27% to a closing price of $14.53. The stock saw 649,005 shares trade hands over the course of the day on 1,378 trades. Given that the stock’s average daily volume over the last month has been 133,751 shares a day, this represents a pretty substantial spike over the norm.

Dicerna Pharmaceuticals has a P/B ratio of 2.87. The stock has traded between $27.33 and $7.61 over the last 52-weeks, its 50-day SMA is now $11.64, and its 200-day SMA $14.75.

Dicerna Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in the discovery and development of treatments for rare inherited diseases involving the liver and for cancers that are genetically defined.

Headquartered in Cambridge, MA, Dicerna Pharmaceuticals has 42 employees and is currently under the leadership of CEO Douglas M. Fambrough.

For a complete fundamental analysis analysis of Dicerna Pharmaceuticals, check out Equities.com’s Stock Valuation Analysis report for DRNA. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

International Western Petroleum Inc

International Western Petroleum Inc is an exploration-stage oil and natural gas company. The Company is engaged in the acquisition, development, and exploration of crude oil and natural gas properties in…

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…


Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…